Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39
Tissue Transplantation01:24

Tissue Transplantation

408
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
408
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.0K
Overview
69.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of cure and survival in vascular graft and endograft infections: a 13-year single-centre cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Predicting total knee replacement in knee osteoarthritis using a machine learning-guided approach in patients of the Osteoarthritis Initiative (OAI).

RMD open·2026
Same author

Clinical and molecular data to predict flares in DMARD optimization in rheumatoid arthritis: a randomized, controlled, open-label, non-inferiority trial.

Rheumatology (Oxford, England)·2026
Same author

[Development of a predictive model for estimating healthcare costs in women with non-metastatic breast cancer].

Revista espanola de salud publica·2025
Same author

Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery.

The Journal of endocrinology·2025
Same author

Mitochondrial DNA haplogroups and circulating cell-free mitochondrial DNA as biomarkers of bronchopulmonary dysplasia.

Pediatric research·2025

Related Experiment Video

Updated: Jul 23, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K

Postoperative Events in Incompatible Living Donor Kidney Transplant Recipients Undergoing Prior Desensitization.

Rubén García-Sobrino1, Dario Vazquez-Martul2, Constantino Fernández-Rivera3

  • 1Department of Urology, Hospital Ribera Povisa, Vigo, España.

Transplantation Proceedings
|July 16, 2023
PubMed
Summary
This summary is machine-generated.

Living donor kidney transplants with ABO-incompatible or HLA-incompatible donors require more transfusions and have larger hematomas, leading to higher reintervention rates. However, overall surgical complication numbers did not significantly differ between incompatible and compatible recipients.

More Related Videos

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K

Related Experiment Videos

Last Updated: Jul 23, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.2K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Immunology

Background:

  • Living donor kidney transplantation (LDKT) is a primary treatment for chronic renal failure.
  • ABO and/or HLA incompatibility limits approximately one-third of LDKT cases.
  • Pre-transplant desensitization programs aim to overcome immunological barriers.

Purpose of the Study:

  • To compare surgical complications and bleeding events in ABO-incompatible (ABOi) and HLA-incompatible (HLAi) kidney transplant recipients undergoing desensitization.
  • To evaluate outcomes in incompatible recipients against ABO-compatible (ABOc) recipients.

Main Methods:

  • Retrospective analysis of 62 ABOi and HLAi LDKT recipients (2009-2019).
  • Comparison with 62 consecutively performed ABOc LDKT recipients.
  • Analysis of surgical complications, peri-graft hematomas (presence, size, reintervention), and postoperative transfusions.

Main Results:

  • Incompatible recipients (ABOi + HLAi) showed a greater number and size of peri-graft hematomas.
  • Higher rates of surgical reintervention and increased blood transfusions were observed in incompatible groups.
  • No statistically significant differences in overall surgical complication rates were found between incompatible and compatible recipients.

Conclusions:

  • Desensitized kidney transplant recipients experience more postoperative bleeding complications, including larger hematomas and increased need for transfusions and reinterventions.
  • Despite increased bleeding events, the overall number of surgical complications did not differ significantly.
  • Pre-transplant desensitization protocols are effective but require careful management of associated bleeding risks.